A concise infertility work-up results in fewer pregnancies
article
OA: gold
CC0
Abstract
STUDY QUESTION: Is pregnancy success rate after a concise infertility work-up the same as pregnancy success rate after the traditional extensive infertility work-up? SUMMARY ANSWER: The ongoing pregnancy rate within a follow-up of 1 year after a concise infertility work-up is significantly lower than the pregnancy success rate after the traditional and extensive infertility work-up. WHAT IS KNOWN ALREADY: Based on cost-effectiveness studies, which have mainly focused on diagnosis, infertility work-up has become less comprehensive. Many centres have even adopted a one-stop approach to their infertility work-up. STUDY DESIGN SIZE DURATION: We performed a historically controlled cohort study. In 2012 and 2013 all new infertile couples (n = 795) underwent an extensive infertility work-up (group A). In 2014 and 2015, all new infertile couples (n = 752) underwent a concise infertility work-up (group B). The follow-up period was 1 year for both groups. Complete follow-up was available for 99.0% of couples in group A and 97.5% in group B. PARTICIPANTS/MATERIALS SETTING METHODS: The extensive infertility work-up consisted of history taking, a gynaecological ultrasound scan, semen analysis, ultrasonographic cycle monitoring, a timed postcoital test, a timed progesterone and chlamydia antibody titre. A hysterosalpingography (HSG) was advised routinely. The concise infertility work-up was mainly based on history taking, a gynaecological ultrasound scan and semen analysis. A HSG was only performed if tubal pathology was suspected or before the start of IUI. Laparoscopy and hormonal tests were only performed if indicated. Couples were treated according to the diagnosis with either expectant management (if the Hunault prognostic score was >30%), ovulation induction (in case of ovulation disorders), IUI in natural cycles (in case of cervical factor), IUI in stimulated cycles (if the Hunault prognostic score was <30%) or IVF/ICSI (in case of tubal factor, advanced female age, severe male factor and if other treatments remained unsuccessful). The primary outcomes were time to pregnancy and the ongoing pregnancy rates in both groups. The secondary outcomes were the number of investigations, the distribution of diagnoses made, the first treatment (started) after infertility work-up and the mode of conception. MAIN RESULTS AND THE ROLE OF CHANCE: < 0.001). LIMITATIONS REASONS FOR CAUTION: This was a historically controlled cohort study; introduction of bias cannot be ruled out. The follow-up rate was similar in the two groups and therefore could not explain the differences in pregnancy rate. WIDER IMPLICATIONS OF THE FINDINGS: Re-introduction of an extensive infertility work-up should be considered as it may lead to higher ongoing pregnancy rates within a year. The therapeutic effects of HSG and timing of intercourse may improve the fertility chance. This finding should be verified in a randomized controlled trial. STUDY FUNDING/COMPETING INTERESTS: No funding was obtained for this study. No conflicts of interest were declared. TRIAL REGISTRATION NUMBER: N/A.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 1997
- Cost-effectiveness of hysterosalpingography, laparoscopy, and Chlamydia antibody testing in subfertile couples 2001
- Establishment of lipiodol as a fertility treatment – Prospective study of the complete innovative treatment data set 2013
References (29)
- Cost-effectiveness of hysterosalpingography, laparoscopy, and Chlamydia antibody testing in subfertile couples via openalex
- Establishment of lipiodol as a fertility treatment – Prospective study of the complete innovative treatment data set via openalex
- Revised American Society for Reproductive Medicine classification of endometriosis: 1996 via openalex
- doi:10.1056/nejm199512073332301 via openalex
- doi:10.1093/humrep/dem251 via openalex
- doi:10.1097/00001703-200208000-00006 via openalex
- doi:10.1093/humrep/deh230 via openalex
- doi:10.1111/j.1471-0528.2008.02070.x via openalex
- doi:10.1093/humrep/deh365 via openalex
- doi:10.1111/aogs.12442 via openalex
- doi:10.1093/humrep/deg366 via openalex
- W2463739750 via openalex
- doi:10.1002/14651858.cd011345 via openalex
- doi:10.1093/humrep/der367 via openalex
- W4285719527 via openalex
- W6637786911 via openalex
- doi:10.1093/humrep/del521 via openalex
- doi:10.1056/nejmoa1612337 via openalex
- doi:10.1093/humrep/deh821 via openalex
- doi:10.1016/s0015-0282(16)56451-6 via openalex
- doi:10.1016/s0015-0282(16)44056-2 via openalex
- doi:10.1093/humrep/deq263 via openalex
- doi:10.1093/humrep/15.9.1953 via openalex
- doi:10.1002/14651858.cd011345.pub2 via openalex
- doi:10.1136/bmj.318.7189.1007a via openalex
- doi:10.1016/j.fertnstert.2012.05.032 via openalex
- doi:10.1016/j.ejogrb.2013.06.042 via openalex
- doi:10.1016/s0140-6736(06)69042-9 via openalex
- doi:10.1136/bmj.317.7157.502 via openalex
SciLite annotations
chemicals 9
progesterone
progesterone
testosterone
estradiol
water
progesterone
chorionic gonadotropin
progesterone
progesterone
organisms 6
rickettsiaformis
rickettsiaformis
rickettsiaformis
human
noordeloos 2009062
human
Source provenance
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- openalex
- last seen: 2026-05-10T10:20:11.957751+00:00
- scilite
- last seen: 2026-05-18T04:26:01.642840+00:00
License: CC0
· commercial use OK